Director Nicholas Haft resigns from Finch Therapeutics Board effective June 23, 2023

Finch Therapeutics Group, Inc.

Nicholas Haft resigned from the Board, effective June 23, 2023.
Resignation was not due to any disagreement with the Company's operations, policies, or practices.
Board composition changes following Haft's departure.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Nicholas Haft

Director

FNCHQ · Finch Therapeutics Group, Inc.

Effective: 2023-06-23
Filed: June 23, 2023, 7:59 PM ET

On June 21, 2023, Nicholas Haft resigned from the Board of Directors (the “Board”) of Finch Therapeutics Group, Inc. (the “Company”), effective as of June 23, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Nicholas Haft resigned as Director at Finch Therapeutics Group, Inc..

Action: resigned
Role: Director

Exact text from the filing

On June 21, 2023, Nicholas Haft resigned from the Board of Directors (the “Board”) of Finch Therapeutics Group, Inc. (the “Company”), effective as of June 23, 2023.

View on SEC.gov

Finch Therapeutics Group, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-173133

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.